Oliceridine Patent Expiration

Oliceridine is Used for managing acute pain through intravenous injection. It was first introduced by Trevena Inc in its drug Olinvyk on Oct 30, 2020.


Oliceridine Patents

Given below is the list of patents protecting Oliceridine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Olinvyk US11077098 Opioid receptor ligands and methods of using and making same Mar 23, 2032 Trevena
Olinvyk US11931350 Opioid receptor ligands and methods of using and making same Mar 23, 2032 Trevena
Olinvyk US8835488 Opioid receptor ligands and methods of using and making same Mar 23, 2032 Trevena
Olinvyk US9309234 Opioid receptor ligands and methods of using and making same Mar 23, 2032 Trevena
Olinvyk US9642842 Opioid receptor ligands and methods of using and making same Mar 23, 2032 Trevena



Oliceridine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List